Unilateral vs. bilateral splanchnic block for hepatobiliary cancer pain: is there a difference?

In patients with hepatobiliary cancer, does unilateral splanchnic block is equally effective as bilateral splanchnic bock in reduction of cancer pain ?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201508001190111

Enrollment

Registered

2015-07-06

Start date

2015-08-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer cancer pain

Interventions

bilatral splanchnic block

unilateral splanchnic block

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with hepatobiliary cancer

Exclusion criteria

Exclusion criteria: coagulopathy infection at site of injection allergy to study drugs

Design outcomes

Primary

Measure	Time frame
reduction of pain intensity assessed by VAS scale	—

Secondary

Measure	Time frame
opioid consumption	—

Countries

Egypt

Contacts

Public Contactdiab hetta

lecturer

diabhetta25@gmail.com+201091090009

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026